United States · Funded startup

Who invested in Carterra

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$10Mraised across 1 round since 2018, from 1 source

Latest round
Round, $10MJan 2018
Investors
1
See who backed them

The rounds

  1. Jan 2018
    Round$10M
    • Telegraph HIll

    Reported by FinSMEs

Founders and team

From the SEC filings it signed: 1 on the team.

  • Janel FillingerExecutive Officeri

On the board, as filediAlexander HerzickJack BallJoe KeeganJohn LilligJosh Eckman

Everyone who backed them

Telegraph HIllno record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 4 firms list Carterra as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.

Ballast Point VenturesPrivate equityPer its own site
Telegraph Hill PartnersVC firmPer its own site
Park City AngelsAngel networkPer its own site
Ballast Point PartnersGrowth equityPer its own site

Quick answers about Carterra

Who invested in Carterra?

Carterra's investors include Telegraph HIll.

How much has Carterra raised?

Carterra has raised $10M across 1 round since 2018.

When did Carterra last raise?

Carterra's most recent round was an Undisclosed round of $10M in Jan 2018.

What was Carterra's biggest round?

Its most recent round, $10M in Jan 2018, is also its largest on record.

Who backed Carterra first?

Carterra's first round on record, in Jan 2018, was backed by Telegraph HIll.

What stage is Carterra at?

Carterra's latest named round is an Undisclosed round, in Jan 2018.

Where is Carterra based?

Carterra is based in the United States.

Companies like Carterra

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.